Adding ianalumab to standard-of-care second-line eltrombopag prolonged the time to treatment failure vs placebo plus eltrombopag in patients with primary immune thrombocytopenia (ITP) in the pivotal ...
1 Hematology Unit, Pathology and Clinical Laboratory Medicine Administration, King Fahad Medical City, Riyadh Second Health Cluster, Riyadh, Saudi Arabia 2 College of Medicine, Alfaisal University, ...
Background: Identifying platelet hyperreactivity is critical for selecting patients who may benefit from antiplatelet therapy in cardiovascular (CV) prevention. We previously developed and validated ...
CONCORD, Calif.--(BUSINESS WIRE)-- Cerus Corporation (CERS) announced today that it will host an industry workshop on the benefits of Pathogen Reduced Cryoprecipitated Fibrinogen Complex, commonly ...
Abstract: Blockchain-based Decentralized Identity (DID) typically employs identity aggregation techniques to support efficient and trustworthy identity authentication in order to meet the requirements ...
Platelets are a class of blood cells exfoliated from bone marrow megakaryocytes and important participants in the blood. Aggregation is a prominent part of the platelets involved in the hemostasis ...
Abstract: In federated learning, malicious attackers may control clients and servers to perform gradient poisoning, forge aggregation results, and infer individual gradient privacy, posing serious ...
Bentracimab effectively reversed ticagrelor's antiplatelet effects, restoring platelet function in minutes for most patients in urgent situations. The REVERSE-IT trial showed 94.3% of patients ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results